0	8	NF-kappa	NF-kappa	NNP
9	22	B-independent	b-independent	JJ
23	34	suppression	suppression	NN
35	37	of	of	IN
38	41	HIV	HIV	NNP
42	52	expression	expression	NN
53	55	by	by	IN
56	64	ascorbic	ascorbic	JJ
65	69	acid	acid	NN
69	70	.	.	.

72	80	Ascorbic	ascorbic	JJ
81	85	acid	acid	NN
86	87	(	(	(
87	96	ascorbate	ascorbate	NN
97	99	or	or	CC
100	107	vitamin	vitamin	NN
108	109	C	C	NNP
109	110	)	)	)
111	114	has	have	VBZ
115	119	been	be	VBN
120	125	shown	show	VBN
126	128	to	to	TO
129	137	suppress	suppress	VB
138	141	the	the	DT
142	151	induction	induction	NN
152	154	of	of	IN
155	158	HIV	HIV	NNP
159	161	in	in	IN
162	170	latently	latently	RB
171	179	infected	infected	JJ
180	181	T	t	NN
182	193	lymphocytic	lymphocytic	JJ
194	199	cells	cell	NNS
200	209	following	follow	VBG
210	221	stimulation	stimulation	NN
222	226	with	with	IN
227	228	a	a	DT
229	234	tumor	tumor	NN
235	243	promoter	promoter	NN
244	245	(	(	(
245	248	PMA	PMA	NNP
248	249	)	)	)
250	253	and	and	CC
254	266	inflammatory	inflammatory	JJ
267	275	cytokine	cytokine	NN
276	277	(	(	(
277	286	TNF-alpha	TNF-alpha	NNP
286	287	)	)	)
287	288	.	.	.

289	291	To	to	TO
292	298	assess	assess	VB
299	306	whether	whether	IN
307	311	this	this	DT
312	322	inhibition	inhibition	NN
323	326	was	be	VBD
327	335	mediated	mediate	VBN
336	339	via	via	IN
340	350	modulation	modulation	NN
351	353	of	of	IN
354	357	the	the	DT
358	366	cellular	cellular	JJ
367	380	transcription	transcription	NN
381	387	factor	factor	NN
387	388	,	,	,
389	397	NF-kappa	NF-kappa	NNP
398	399	B	B	NNP
399	400	,	,	,
401	403	we	we	PRP
404	411	carried	carry	VBD
412	415	out	out	RP
416	419	gel	gel	NN
420	425	shift	shift	NN
426	434	analysis	analysis	NN
435	437	on	on	IN
438	445	nuclear	nuclear	JJ
446	454	extracts	extract	NNS
455	463	prepared	prepare	VBN
464	469	under	under	IN
470	479	different	different	JJ
480	490	conditions	condition	NNS
491	493	of	of	IN
494	498	cell	cell	NN
499	510	stimulation	stimulation	NN
511	513	in	in	IN
514	517	the	the	DT
518	526	presence	presence	NN
527	529	or	or	CC
530	537	absence	absence	NN
538	540	of	of	IN
541	550	ascorbate	ascorbate	NN
550	551	,	,	,
552	568	N-acetylcysteine	N-acetylcysteine	NNP
569	570	(	(	(
570	573	NAC	NAC	NNP
573	574	)	)	)
574	575	,	,	,
576	578	or	or	CC
579	589	zidovudine	zidovudine	NN
590	591	(	(	(
591	594	AZT	AZT	NNP
594	595	)	)	)
595	596	.	.	.

597	609	Pretreatment	Pretreatment	NNP
610	612	of	of	IN
613	618	ACH-2	ach-2	NN
619	620	T	t	NN
621	626	cells	cell	NNS
627	629	by	by	IN
630	633	NAC	NAC	NNP
634	642	followed	follow	VBN
643	645	by	by	IN
646	657	stimulation	stimulation	NN
658	662	with	with	IN
663	666	PMA	PMA	NNP
666	667	,	,	,
668	677	TNF-alpha	TNF-alpha	NNP
677	678	,	,	,
679	681	or	or	CC
682	690	hydrogen	hydrogen	NN
691	699	peroxide	peroxide	NN
700	701	(	(	(
701	705	H2O2	h2o2	NN
705	706	)	)	)
707	715	resulted	result	VBD
716	718	in	in	IN
719	725	strong	strong	JJ
726	737	suppression	suppression	NN
738	740	of	of	IN
741	749	NF-kappa	NF-kappa	NNP
750	751	B	B	NNP
752	762	activation	activation	NN
762	763	.	.	.

764	766	In	in	IN
767	775	contrast	contrast	NN
775	776	,	,	,
777	784	neither	neither	CC
785	794	ascorbate	ascorbate	NN
795	798	nor	nor	CC
799	802	AZT	AZT	NNP
803	811	affected	affect	VBD
812	820	NF-kappa	NF-kappa	NNP
821	822	B	B	NNP
823	831	activity	activity	NN
832	837	under	under	IN
838	841	all	all	DT
842	847	three	three	CD
848	857	induction	induction	NN
858	868	conditions	condition	NNS
869	871	in	in	IN
872	875	the	the	DT
876	881	ACH-2	ach-2	NN
882	886	cell	cell	NN
887	891	line	line	NN
891	892	.	.	.

893	902	Ascorbate	Ascorbate	NNP
903	906	and	and	CC
907	910	AZT	AZT	NNP
911	915	also	also	RB
916	919	had	have	VBD
920	922	no	no	DT
923	929	effect	effect	NN
930	932	on	on	IN
933	941	NF-kappa	NF-kappa	NNP
942	943	B	B	NNP
944	954	activation	activation	NN
955	964	following	follow	VBG
965	975	TNF-alpha-	tnf-alpha-	NN
976	978	or	or	CC
979	990	PMA-induced	pma-induced	JJ
991	1002	stimulation	stimulation	NN
1003	1005	of	of	IN
1006	1008	U1	u1	NN
1009	1021	promonocytic	promonocytic	JJ
1022	1027	cells	cell	NNS
1027	1028	.	.	.

1029	1034	These	these	DT
1035	1042	results	result	NNS
1043	1050	suggest	suggest	VBP
1051	1055	that	that	IN
1056	1059	the	the	DT
1060	1069	molecular	molecular	JJ
1070	1079	mechanism	mechanism	NN
1080	1082	of	of	IN
1083	1086	HIV	HIV	NNP
1087	1097	inhibition	inhibition	NN
1098	1100	by	by	IN
1101	1110	ascorbate	ascorbate	NN
1111	1113	is	be	VBZ
1114	1117	not	not	RB
1118	1126	mediated	mediate	VBN
1127	1130	via	via	IN
1131	1139	NF-kappa	NF-kappa	NNP
1140	1141	B	B	NNP
1142	1152	inhibition	inhibition	NN
1152	1153	,	,	,
1154	1160	unlike	unlike	IN
1161	1165	that	that	DT
1166	1170	seen	see	VBN
1171	1175	with	with	IN
1176	1181	other	other	JJ
1182	1194	antioxidants	antioxidant	NNS
1194	1195	.	.	.